ARTICLE | Finance
Analyst picks & changes
May 15, 1995 7:00 AM UTC
Genentech Inc. (GNE)
Cowen's Lonergan said Phase I data from GNE's 41-patient open-label trial of NGF (nerve growth factor) in chemotherapy-induced neuropathy provides support for further studies. ...